These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 27015745

  • 1. Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology.
    Oda T, Ogata S, Kawaguchi S, Minabe S, Dokyu M, Takahashi H, Kumazawa F, Shimazaki H, Takano M, Hase K, Ozeki Y, Kanoh S, Nakanishi K.
    Diagn Cytopathol; 2016 Jun; 44(6):499-504. PubMed ID: 27015745
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD, Panizo A, Toledo GR, Sola JJ, Pardo-Mindán J.
    Cancer; 2001 Feb 25; 93(1):68-72. PubMed ID: 11241268
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The importance of EZH2 and MOC-31 expression in the differential diagnosis of benign and malignant effusions.
    Sadullahoglu C, Nart D, Veral A.
    Diagn Cytopathol; 2017 Feb 25; 45(2):118-124. PubMed ID: 28024110
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic Value of the EZH2 Immunomarker in Malignant Effusion Cytology.
    Ang PP, Tan GC, Karim N, Wong YP.
    Acta Cytol; 2020 Feb 25; 64(3):248-255. PubMed ID: 31352449
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology.
    Jo VY, Cibas ES, Pinkus GS.
    Cancer Cytopathol; 2014 Apr 25; 122(4):299-306. PubMed ID: 24421209
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Utility of MOC-31 monoclonal antibody in differentiating metastatic adenocarcinoma cells and reactive mesothelial cells in effusion cytology.
    Patil B, Shivkumar V, Gangane N.
    Indian J Pathol Microbiol; 2018 Apr 25; 61(1):90-93. PubMed ID: 29567891
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
    Davidson B, Risberg B, Kristensen G, Kvalheim G, Emilsen E, Bjåmer A, Berner A.
    Virchows Arch; 1999 Jul 25; 435(1):43-9. PubMed ID: 10431845
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.